2 weeks Ago By Defense World Staff
Triad Wealth Partners LLC bought a new position in shares of JPMorgan Chase & Co. (NYSE:JPM) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 7,459 shares of the financial services provider’s stock, valued at approximately $1,788,000.
Other hedge funds also recently added to or reduced their stakes in the company. Mizuho Securities Co. Ltd.
purchased a new stake in shares of JPMorgan Chase & Co. in the 3rd quarter valued at approximately $25,000. Midwest Capital Advisors LLC purchased a new stake in shares of JPMorgan Chase & Co.
in the 4th quarter valued at approximately $43,000. Collier Financial purchased a new stake in shares of JPMorgan Chase & Co. in the 4th quarter valued at approximately $45,000.
Lowe Wealth Advisors LLC increased its position in shares of JPMorgan Chase & Co. by 34.0% in the 4th quarter.
Lowe Wealth Advisors LLC now owns 201 shares of the financial services provider’s stock valued at $48,000 after purchasing an additional 51 shares during the last quarter. Finally, Kieckhefer Group LLC purchased a new position in shares of JPMorgan Chase & Co. in the 4th quarter valued at $50,000.
71.55% of the stock is currently owned by institutional investors and hedge funds. Insider ActivityIn other JPMorgan Chase & Co.
news, CEO Troy L. Rohrbaugh sold 37,500 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $269.
84, for a total transaction of $10,119,000.00. Following the transaction, the chief executive officer now owns 158,381 shares in the company, valued at $42,737,529.
04. This trade represents a 19.14 % decrease in their ownership of the stock.
The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, General Counsel Stacey Friedman sold 3,303 shares of the stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $253.
94, for a total value of $838,763.82. Following the transaction, the general counsel now owns 47,620 shares in the company, valued at approximately $12,092,622.
80. This trade represents a 6.49 % decrease in their position.
The disclosure for this sale can be found here. Insiders have sold 46,326 shares of company stock worth $12,448,445 in the last 90 days. Company insiders own 0.
79% of the company’s stock. JPMorgan Chase & Co. Price PerformanceShares of NYSE JPM opened at $232.
94 on Friday. JPMorgan Chase & Co. has a twelve month low of $179.
20 and a twelve month high of $280.25. The company has a current ratio of 0.
88, a quick ratio of 0.89 and a debt-to-equity ratio of 1.24.
The company has a market capitalization of $651.31 billion, a price-to-earnings ratio of 11.80, a PEG ratio of 2.
83 and a beta of 1.10. The firm has a 50-day moving average of $258.
29 and a two-hundred day moving average of $238.70. JPMorgan Chase & Co.
(NYSE:JPM – Get Free Report) last posted its quarterly earnings data on Wednesday, January 15th. The financial services provider reported $4.81 EPS for the quarter, beating analysts’ consensus estimates of $4.
03 by $0.78. JPMorgan Chase & Co.
had a net margin of 20.96% and a return on equity of 16.99%.
The company had revenue of $42.77 billion during the quarter, compared to analyst estimates of $41.90 billion.
During the same period in the prior year, the firm earned $3.04 earnings per share. The business’s quarterly revenue was up 10.
9% on a year-over-year basis. As a group, analysts expect that JPMorgan Chase & Co. will post 18.
1 earnings per share for the current fiscal year. Wall Street Analyst Weigh InA number of research analysts recently commented on the stock. Bank of America increased their target price on shares of JPMorgan Chase & Co.
from $260.00 to $280.00 and gave the company a “buy” rating in a research report on Tuesday, January 7th.
Oppenheimer downgraded shares of JPMorgan Chase & Co. from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 20th. Barclays increased their target price on shares of JPMorgan Chase & Co.
from $304.00 to $330.00 and gave the company an “overweight” rating in a research report on Thursday, January 16th.
Citigroup increased their target price on shares of JPMorgan Chase & Co. from $215.00 to $250.
00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Finally, Keefe, Bruyette & Woods increased their target price on shares of JPMorgan Chase & Co. from $257.
00 to $264.00 and gave the company a “market perform” rating in a research report on Thursday, January 16th. Ten analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock.
Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $252.89.View Our Latest Report on JPMorgan Chase & Co.
About JPMorgan Chase & Co. (Free Report)JPMorgan Chase & Co is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and services in all capital markets, including advising on corporate strategy and structure, capital raising in equity and debt markets, risk management, market making in cash securities and derivative instruments, and brokerage and research.
Featured ArticlesFive stocks we like better than JPMorgan Chase & Co.Special Purpose Acquisition Company (SPAC) What You Need to Know Rubrik Stock’s V-Bottom Reversal Signals a Major Rally AheadNYSE Stocks Give Investors a Variety of Quality Options How Super Micro Computer Stock Is Defying the Market Sell-OffUsing the MarketBeat Stock Split CalculatorAppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM – Free Report)..
